SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $209,000 | -30.1% | 3,684 | -7.9% | 0.00% | – |
| Q1 2021 | $299,000 | -21.5% | 4,000 | -9.1% | 0.00% | – |
| Q4 2020 | $381,000 | +41.6% | 4,400 | 0.0% | 0.00% | – |
| Q3 2020 | $269,000 | -87.8% | 4,400 | -94.3% | 0.00% | -100.0% |
| Q1 2020 | $2,213,000 | -91.0% | 77,056 | -77.3% | 0.01% | -88.4% |
| Q4 2019 | $24,523,000 | -63.3% | 339,698 | -28.6% | 0.04% | -38.6% |
| Q3 2019 | $66,760,000 | -11.2% | 475,870 | +15.9% | 0.07% | -56.8% |
| Q2 2019 | $75,190,000 | +6.3% | 410,672 | -7.6% | 0.16% | +3.8% |
| Q1 2019 | $70,709,000 | +62.6% | 444,572 | -2.1% | 0.16% | +43.1% |
| Q4 2018 | $43,493,000 | -21.4% | 454,044 | +16.0% | 0.11% | -6.8% |
| Q3 2018 | $55,306,000 | -7.3% | 391,548 | +2.7% | 0.12% | -18.2% |
| Q2 2018 | $59,684,000 | -4.9% | 381,291 | -2.1% | 0.14% | -7.7% |
| Q1 2018 | $62,733,000 | -18.9% | 389,479 | -17.1% | 0.16% | -22.1% |
| Q4 2017 | $77,350,000 | +227.5% | 469,610 | +23.9% | 0.20% | +197.0% |
| Q3 2017 | $23,615,000 | -25.6% | 379,045 | -21.0% | 0.07% | -31.6% |
| Q2 2017 | $31,734,000 | +4.4% | 480,013 | +12.2% | 0.10% | -1.0% |
| Q1 2017 | $30,410,000 | +102.9% | 427,889 | +45.8% | 0.10% | +76.8% |
| Q4 2016 | $14,988,000 | -5.2% | 293,542 | -14.5% | 0.06% | -5.1% |
| Q3 2016 | $15,815,000 | +10.1% | 343,429 | -21.3% | 0.06% | +5.4% |
| Q2 2016 | $14,367,000 | +1083.4% | 436,538 | +957.0% | 0.06% | +1020.0% |
| Q1 2016 | $1,214,000 | – | 41,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |